A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis - NCT05862272

Percent change from baseline in BMD at Month 48 on-treatment at lumbar spine (L1-L4) in women with uterine fibroids., Percent change from baseline in BMD at Month 48 on-treatment at lumbar spine (L1-L4) in women with endometriosis., Percent change from baseline in BMD at Month 48 on-treatment at total hip and femoral neck in women with uterine fibroids., (and 14 more...)